Cerebrolysin
Cerebrolysin is a preparation derived from pig brain tissue containing small brain-protective peptides and amino acids. It is approved in many countries (but not the United States) for stroke, traumatic brain injury, and dementia. It is one of the most extensively studied brain peptide formulations.
A leading innovator in research chemicals.
|Exclusive OfferUse our affiliate link and code PEPTIDEWIKI at checkout to unlock your 10% discount, every time you use the code.
Shop NowFor research purposes only. PeptideWiki may earn a commission at no extra cost to you.
Cerebrolysin
For research purposes only. PeptideWiki may earn a commission at no extra cost to you.
Overview of Cerebrolysin
Provides neurotrophic factor-like activity through a mixture of brain-derived peptides, supporting neuronal survival, synaptic plasticity, and neurogenesis.
Contains peptides with activity resembling BDNF, GDNF, NGF, and CNTF, supporting neuronal survival and differentiation.
Enhances synaptic plasticity and long-term potentiation (proposed), which may improve learning and memory formation.
Stimulates neurogenesis in the hippocampus (proposed), potentially relevant to recovery from brain injury.
Reduces excitotoxic damage by modulating calcium influx and glutamate signaling in neurons under stress.
Inhibits calpain-mediated cytoskeletal breakdown (proposed), preserving neuronal structural integrity after injury.
Reduces amyloid-beta pathology and tau phosphorylation in preclinical Alzheimer's models (proposed).
Improves functional outcomes in acute ischemic stroke trials, with benefits in motor and cognitive recovery.
May reduce infarct volume and promote perilesional neuroplasticity (proposed), supporting post-stroke rehabilitation
Read Full Cerebrolysin Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Cognition, Mood & Neuroprotection